Back

Genetic testing for SCA27B in Korean Multiple System Atrophy

Lass, J.; Berselli, M.; Rioux, D.; Schaake, S.; Follett, J.; Bravo, J. E.; Veit, A. D.; Ronchetti, W.; Reiff, S. B.; Huentelman, M. J.; Vuzman, D.; Bower, P.; Park, P. J.; Khurana, V.; Trinh, J.; Jeon, B.; Kim, H.-J.; Farrer, M. J.

2024-10-22 neurology
10.1101/2024.10.21.24315855 medRxiv
Show abstract

FGF14 (GAA)n repeat expansions are a common cause of idiopathic late-onset ataxia (SCA27B). The cerebellar form of multiple system atrophy (MSA) has comparable clinical features, albeit faster progression. Hence, we performed an analysis of FGF14 genomic variability in a South Korean cohort of 199 patients with probable MSA, compared with 1,048 ethnically-matched controls. All whole genome sequences (WGS) are depicted on a computational genome analysis platform, CGAP, to enable storage, visualization and analysis for partners of the International MSA Coalition. The size of the FGF14 (GAA)n repeat was also assessed by genomic PCR, and by interrogating WGS data using Expansion Hunter (EH) with an extensive catalogue of potential repeats. However, MSA samples were not significantly different to matched Korean controls, and only three MSA patients showed possible abnormal FGF14 (GAA)n expansions >300bp. Nevertheless, as PCR and EH findings were often discordant, a subset of samples with expansions was validated by long-read sequencing. Some intermediate expansions (>150 bp) were found in 6.9% (27/392) of controls compared to 13.4% (46/344) in MSA, though overall our results suggest FGF14 (GAA)n repeat expansions do not influence susceptibility to MSA in Korean patients and highlight challenges inherent in this genetic testing.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Neurology Genetics
15 papers in training set
Top 0.1%
23.4%
2
Annals of Clinical and Translational Neurology
34 papers in training set
Top 0.1%
13.5%
3
Journal of Medical Genetics
29 papers in training set
Top 0.1%
8.2%
4
Movement Disorders
71 papers in training set
Top 0.2%
7.0%
50% of probability mass above
5
Human Genetics and Genomics Advances
84 papers in training set
Top 0.6%
3.4%
6
Genetics in Medicine
78 papers in training set
Top 0.4%
3.4%
7
Scientific Reports
3612 papers in training set
Top 37%
2.9%
8
Annals of Neurology
64 papers in training set
Top 0.5%
2.8%
9
Brain
168 papers in training set
Top 1%
2.6%
10
Orphanet Journal of Rare Diseases
21 papers in training set
Top 0.2%
2.2%
11
Neurology
50 papers in training set
Top 0.7%
2.0%
12
European Journal of Neurology
22 papers in training set
Top 0.3%
1.8%
13
Genome Medicine
183 papers in training set
Top 3%
1.8%
14
The American Journal of Human Genetics
234 papers in training set
Top 2%
1.5%
15
Clinical and Translational Medicine
31 papers in training set
Top 0.4%
1.5%
16
Neuropathology and Applied Neurobiology
15 papers in training set
Top 0.2%
1.4%
17
Human Mutation
34 papers in training set
Top 0.4%
1.2%
18
Muscle & Nerve
10 papers in training set
Top 0.3%
0.9%
19
Nature Communications
5641 papers in training set
Top 55%
0.9%
20
Journal of Alzheimer’s Disease
50 papers in training set
Top 1%
0.9%
21
The Journal of Molecular Diagnostics
39 papers in training set
Top 0.6%
0.9%
22
International Journal of Molecular Sciences
494 papers in training set
Top 16%
0.6%
23
Genetics in Medicine Open
11 papers in training set
Top 0.3%
0.6%
24
eBioMedicine
183 papers in training set
Top 7%
0.6%
25
Med
39 papers in training set
Top 0.8%
0.6%
26
Journal of Neurology
28 papers in training set
Top 1%
0.6%
27
Scientific Data
209 papers in training set
Top 4%
0.5%
28
Frontiers in Molecular Biosciences
102 papers in training set
Top 3%
0.5%
29
Cancer Medicine
26 papers in training set
Top 1%
0.5%
30
Genome Biology
637 papers in training set
Top 10%
0.5%